Washington, as part of a bipartisan coalition of 45 states and territories, has reached settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma to resolve allegations the generic drug ...

Detailed price information for Bausch & Lomb Corp (BLCO-N) from The Globe and Mail including charting and trades.

Bausch + Lomb Corporation is down 9.13 percent, losing $1.58 to $15.72 on Monday. The decline follows the announcement that Thomas J. Appio, CEO of parent company Bausch Health, h ...

<?xml encoding="utf-8" ?> Bausch + Lomb Corp. BLCO stock fell nearly 10% on Monday after the eye care company announced an ...

Brent Saunders exits as Bausch + Lomb CEO by mutual agreement, replaced interim by Thomas Appio. Shares down 3%. Company to ...

Saunders' latest spell as CEO started in 2023, as Bausch Health worked to spin Bausch + Lomb out as an independent public ...

Oct 12 (Reuters) - Bausch + Lomb said on Monday that CEO Brent Saunders will depart the company after a mutual agreement with ...

Bausch + Lomb has named Thomas Appio as its interim chief executive. Appio will succeed Brent Saunders, who will depart the company, the Canadian eye-health company said Monday.

Less than four years after returning to Bausch + Lomb to lead the eye health company following its split from Bausch Health, ...

Bausch + Lomb said on Monday that CEO Brent Saunders ​will depart the company after a mutual agreement with the board, and ...

The silicone hydrogel daily disposable contact lenses feature a design based on the eye’s natural blink patterns ...

Implanting different IOLs in refractive lens exchange may improve patient satisfaction, according to a speaker at Refractive ...